PPTA members produce in approximately 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide.
North America Members
Access Plasma LLC
B Positive National Blood Services LLC
BioLife Plasma Services
Blood and Plasma Research Inc.
The Interstate Companies
Plasmapunkt Favoriten GmbH
Ruhr-Plasma-Zentrum Bochum GmbH
Southern Blood Services
Abbott Laboratories Diagnostic Division
Blood Group Alliance
Lychem International Ltd.
Marketing Research Bureau, Inc.
Therapure Biopharma Inc.
IN MEMORIAM: MENSO BULT +
Menso Bult, European Manager for Plasma Protein Therapeutic Association’s (PPTA) global access activities, passed away after a long illness on March 3, 2014.
Rare Disease Day Congressional Tele-Town Hall +
On February 28, 2014, the Plasma Protein Therapeutics Association (PPTA) hosted a Rare Disease Day Congressional Tele-Town Hall featuring remarks by Congressman Leonard Lance (NJ-7), Co-Chair of the Congressional Rare Disease Caucus, and Dr. Stephen Groft, Pharm. D., Former Director of the Office of Rare Disease Research, National Institutes of Health (NIH).Read More
PPTA Recognizes International Rare Disease Day 2014 +
The Plasma Protein Therapeutics Association (PPTA) joins over 300 organizations in 56 countries in recognizing the 7th annual International Rare Disease Day on February 28.Read More
The Source, the international magazine of the plasma protein therapeutics industry is published quarterly.
Read the current issue.